200 related articles for article (PubMed ID: 17876041)
21. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway.
Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O
PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301
[TBL] [Abstract][Full Text] [Related]
22. New selective estrogen and androgen receptor modulators.
Clarke BL; Khosla S
Curr Opin Rheumatol; 2009 Jul; 21(4):374-9. PubMed ID: 19412100
[TBL] [Abstract][Full Text] [Related]
23. Effects of long-term administration of N-3 polyunsaturated fatty acids (PUFA) and selective estrogen receptor modulator (SERM) derivatives in ovariectomized (OVX) mice.
Zeitlin L; Segev E; Fried A; Wientroub S
J Cell Biochem; 2003 Oct; 90(2):347-60. PubMed ID: 14505351
[TBL] [Abstract][Full Text] [Related]
24. Benzothiophene and naphthalene derived constrained SERMs.
Wallace OB; Bryant HU; Shetler PK; Adrian MD; Geiser AG
Bioorg Med Chem Lett; 2004 Oct; 14(20):5103-6. PubMed ID: 15380208
[TBL] [Abstract][Full Text] [Related]
25. The selective estrogen receptor modulators in breast cancer prevention.
Li F; Dou J; Wei L; Li S; Liu J
Cancer Chemother Pharmacol; 2016 May; 77(5):895-903. PubMed ID: 26787504
[TBL] [Abstract][Full Text] [Related]
26. Benzothiophene Selective Estrogen Receptor Modulators Provide Neuroprotection by a novel GPR30-dependent Mechanism.
Abdelhamid R; Luo J; Vandevrede L; Kundu I; Michalsen B; Litosh VA; Schiefer IT; Gherezghiher T; Yao P; Qin Z; Thatcher GR
ACS Chem Neurosci; 2011 May; 2(5):256-268. PubMed ID: 21731800
[TBL] [Abstract][Full Text] [Related]
27. Modulators of androgen and estrogen receptor activity.
Clarke BL; Khosla S
Crit Rev Eukaryot Gene Expr; 2010; 20(4):275-94. PubMed ID: 21395502
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide transcriptional regulation of estrogen receptor targets in fallopian tube cells and the role of selective estrogen receptor modulators.
Moyle-Heyrman G; Schipma MJ; Dean M; Davis DA; Burdette JE
J Ovarian Res; 2016 Feb; 9():5. PubMed ID: 26879975
[TBL] [Abstract][Full Text] [Related]
29. Selective estrogen receptor modulator BC-1 activates antioxidant signaling pathway in vitro via formation of reactive metabolites.
Yu BL; Mai ZX; Liu XX; Huang ZF
Acta Pharmacol Sin; 2013 Mar; 34(3):373-9. PubMed ID: 23334240
[TBL] [Abstract][Full Text] [Related]
30. Nitrosation, nitration, and autoxidation of the selective estrogen receptor modulator raloxifene by nitric oxide, peroxynitrite, and reactive nitrogen/oxygen species.
Toader V; Xu X; Nicolescu A; Yu L; Bolton JL; Thatcher GR
Chem Res Toxicol; 2003 Oct; 16(10):1264-76. PubMed ID: 14565768
[TBL] [Abstract][Full Text] [Related]
31. The naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.
Gherezghiher TB; Michalsen B; Chandrasena RE; Qin Z; Sohn J; Thatcher GR; Bolton JL
Chem Biol Interact; 2012 Mar; 196(1-2):1-10. PubMed ID: 22290292
[TBL] [Abstract][Full Text] [Related]
32. [Effect of selective estrogen receptor modulators on estrogen-sensitive tissues].
Jirecek S; Pavo I; Huber JC
Gynakol Geburtshilfliche Rundsch; 1999; 39(4):184-90. PubMed ID: 10629380
[TBL] [Abstract][Full Text] [Related]
33. Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass.
Goldstein SR; Bhattoa HP; Neven P; Cox DA; Dowsett SA; Alam J; Sipos A; Muram D
Menopause; 2012 Jan; 19(1):41-7. PubMed ID: 21993078
[TBL] [Abstract][Full Text] [Related]
34. "Non-hypercalcemic" analogs of 1alpha,25 dihydroxy vitamin D augment the induction of creatine kinase B by estrogen and selective estrogen receptor modulators (SERMS) in osteoblast-like cells and rat skeletal organs.
Somjen D; Waisman A; Weisman Y; Kaye AM
J Steroid Biochem Mol Biol; 2000; 72(1-2):79-88. PubMed ID: 10731641
[TBL] [Abstract][Full Text] [Related]
35. Arzoxifene: the development and clinical outcome of an ideal SERM.
Munster PN
Expert Opin Investig Drugs; 2006 Mar; 15(3):317-26. PubMed ID: 16503767
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of Human Sulfotransferase 2A1-Catalyzed Sulfonation of Lithocholic Acid, Glycolithocholic Acid, and Taurolithocholic Acid by Selective Estrogen Receptor Modulators and Various Analogs and Metabolites.
Bansal S; Lau AJ
J Pharmacol Exp Ther; 2019 Jun; 369(3):389-405. PubMed ID: 30918069
[TBL] [Abstract][Full Text] [Related]
37. Quinone formation as a chemoprevention strategy for hybrid drugs: balancing cytotoxicity and cytoprotection.
Dunlap T; Chandrasena RE; Wang Z; Sinha V; Wang Z; Thatcher GR
Chem Res Toxicol; 2007 Dec; 20(12):1903-12. PubMed ID: 17975886
[TBL] [Abstract][Full Text] [Related]
38. Current status of selective estrogen receptor modulators (SERMs).
Conzen SD
Cancer J; 2003; 9(1):4-14. PubMed ID: 12602762
[No Abstract] [Full Text] [Related]
39. Selective estrogen receptor modulators (SERMs) enhance neurogenesis and spine density following focal cerebral ischemia.
Khan MM; Wakade C; de Sevilla L; Brann DW
J Steroid Biochem Mol Biol; 2015 Feb; 146():38-47. PubMed ID: 24815952
[TBL] [Abstract][Full Text] [Related]
40. [Selective estrogen receptors modulators (SERMs): biochemistry, pharmacology, and clinical use in gynecology].
Terán Dávila J; Teppa Garrán AD
Ginecol Obstet Mex; 2005 Aug; 73(8):424-35. PubMed ID: 16304968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]